KellBenx Obtains $2,500,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01f3ab03-3e90-437d-a112-695f00483860&Preview=1 -
Date
4/21/2011 -
Company Name
KellBenx -
Mailing Address
61 Alhambra Road Massapequa, NY 11758 -
Company Description
KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood. Our focus is to improve women’s healthcare and one of our first tests is in the area of non-invasive prenatal diagnosis (NIPD) for genetic disorders. -
Website
http://www.kellbenx.com -
Transaction Type
Venture Equity -
Transaction Amount
$2,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The funds will be used to launch an IRB-approved clinical trial and build our Long Island laboratory to analyze the data we are producing. -
M&A Terms
-
Venture Investor
Undisclosed
